| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $88.60B | $80.74B | $68.92B |
| YoY Revenue Growth % | +9.7% | +17.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $9.30B | $6.54B | $3.56B |
| Operating Margin % | 10.5% | 8.1% | 5.2% |
| Net Income (GAAP) | $6.73B | $4.77B | $3.19B |
| EBITDA (Normalized) | $11.40B | $8.64B | $6.04B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $10.57B | $7.16B | $7.88B |
| Capital Expenditures (CapEx) | $2.63B | $2.63B | $3.10B |
| Free Cash Flow (FCF) | $7.94B | $4.53B | $4.78B |
| FCF Margin % | 9.0% | 5.6% | 6.9% |
| Return on Invested Capital (ROIC %) | 7.0% | 5.2% | 3.1% |
| Cash & Short-Term Equivalents | $7.43B | $5.58B | — |
| Total Debt (Short + Long Term) | $46.77B | $45.41B | $34.63B |
| Total Stockholders' Equity | $65.25B | $60.16B | $71.04B |